Low-dose corticosteroids in HBsAg-negative, anti-HBc-positive individuals are typically low-risk as compared to the high risk associated with moderate to high doses used for four or more weeks in ...

We similarly followed 16 children of hepatitis B surface antigen (HBsAg)-positive mothers. Results: Of low risk infants receiving a plasma-derived vaccine, 41% (42 of 102) of those whose primary ...

编者按：慢性乙型肝炎（CHB）是全球重大健康问题，每年导致超过 82万人死亡，其中大部分是由于病毒感染相关肝硬化和肝细胞癌（HCC）所造成。在CHB感染的不同阶段，乙型肝炎表面抗原（HBsAg）和e抗原（HBeAg）水平的血清学特征随之发生变化。在CHB患者中，HBeAg阳性且HBsAg低水平的患者虽占比较少，但疾病风险不容忽视。既往研究表明，该类患者可能与显著肝纤维化、肝硬化及肝癌风险增加有关， ...

HBsAg positive, HBeAb positive, low-to-undetectable HBV DNA (<2000 IU/ml or <10 4 copies/ml), normal aminotransferases, no active liver disease, residual risk of hepatocellular carcinoma ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

It should include a "triple" panel of HBsAg, antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti ... further grouped into low, medium, and high ...

showing significant reductions in HBsAg levels compared to placebo. Preliminary data from an additional cohort receiving imdusiran, VTP-300, and low doses of nivolumab are expected in the second ...